ClinicalTrials.Veeva

Menu

The Role of the Vagus Nerve in Tumor-to-Brain Communication in Lung Cancer Patients

R

Rambam Health Care Campus

Status

Unknown

Conditions

Lung Cancer

Treatments

Device: PET/CT imaging

Study type

Interventional

Funder types

Other

Identifiers

NCT00397124
vagusCTIL

Details and patient eligibility

About

the aim of this study is to measure brain metabolism in patients with lung cancer.FDG uptake in the brain in patients with malignant tumors will be compared to the amount of tracer activity found in patients who have benign pulmonary process. if differences between the brain uptake of FDG in the two groups will be found, further assessment will be performed in order to evaluate if such differences could be attributed and specifically localized to the brain regions innervated by the vagus

Sex

All

Ages

35 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with SPN referred for routine whole body FDG-PET imaging
  • patients with NSCLC and patients with no evidence of lung cancer on further follow up

Exclusion criteria

  • patients with a clinical history of vagotomy, abdominal surgery. brain tumor, brain trauma or CVA. or those with a systemic inflammatory disease

Trial contacts and locations

1

Loading...

Central trial contact

Alex Frenkel, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems